Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Anomilie
    Member
    • Jun 2013
    • 13

    Limma Voom Differential Splicing diffSplice() error

    Hi,

    I've been following the user's guide for Limma voom to perform differential splicing analysis and I have encountered a few problems.

    Firstly, In chapter 15.4 the following line of code produces and error:

    Code:
    dge <- dge[A>10,,keep.lib.sizes=FALSE]
    Error in object[[a]][i, , drop = FALSE] : incorrect number of dimensions
    If I perform filtering using the following code which I believe does something similar

    Code:
     
    isexpr <- rowSums(dge$counts) > 10
    x <- x[isexpr,]
    dge <- calcNormFactors(x)
    And then continue with the following as stated in the documentation I get an error:

    Code:
    v <- voom(dge,design,plot=TRUE)
    fit <- lmFit(v, design)
    
    ex <- diffSplice(fit, geneid="GeneID")
    Error: could not find function "diffSplice"
    Is there something (perhaps very stupid) that I'm doing wrong??

    Thanks in advance
    Last edited by Anomilie; 08-04-2014, 08:17 PM.
  • Cytosine
    Member
    • Mar 2014
    • 22

    #2
    Please provide sessionInfo() so we can better assist you...

    Code:
    dge <- dge[A>10[COLOR="Red"],,[/COLOR]keep.lib.sizes=FALSE]
    Error in object[[a]][i, , drop = FALSE] : incorrect number of dimensions
    I see a double "," in there. That's causing your number of dimension error.

    Code:
    Error: could not find function "diffSplice"
    Update Limma if you have an old version.

    Comment

    • Anomilie
      Member
      • Jun 2013
      • 13

      #3
      The double quote is directly copied from the documentation and is apparently requirement for subsetting the DGEList object.

      the following code sorted out that issue (in case someone else has similar problems)

      Code:
      dge <- DGEList(counts=raw_data, genes=geneID)
      In regards to the diffSplice error, the error message seems fairly obvious now, I had to update limma to version 3.20.

      Thanks for your reply Cytosine

      While on the topic of diffSplice, would you know the statistical difference between using that function and performing the DE with the standard limma voom pipeline using eBayes(fit)?
      Last edited by Anomilie; 08-04-2014, 11:42 PM.

      Comment

      • Gordon Smyth
        Member
        • Apr 2011
        • 91

        #4
        Originally posted by Anomilie View Post
        While on the topic of diffSplice, would you know the statistical difference between using that function and performing the DE with the standard limma voom pipeline using eBayes(fit)?
        It is exactly equivalent to a voom eBayes pipeline, but adapted to assess differential splicing instead of differential expression.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:41 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        45 views
        0 reactions
        Last Post SEQadmin2  
        Working...